RPS-BLAST 2.2.26 [Sep-21-2011]
Database: CDD.v3.10
44,354 sequences; 10,937,602 total letters
Searching..................................................done
Query= psy11627
(291 letters)
>gnl|CDD|199822 cd10497, MH2_SMAD_1_5_9, C-terminal Mad Homology 2 (MH2) domain in
SMAD1, SMAD5 and SMAD9. The MH2 domain is located at
the C-terminus of the SMAD (small mothers against
decapentaplegic) family of proteins, which are signal
transducers and transcriptional modulators that mediate
multiple signaling pathways. The MH2 domain is
responsible for type I receptor interaction,
phosphorylation-triggered homo- and
hetero-oligomerization, and transactivation. It is
negatively regulated by the N-terminal MH1 domain, which
prevents it from forming a complex with SMAD4. SMAD1,
SMAD5 and SMAD9 (also known as SMAD8), are receptor
regulated SMADs (R-SMADs). SMAD1 plays an essential role
in bone development and postnatal bone formation through
activation by bone morphogenetic protein (BMP) type 1
receptor kinase. SMAD5 is involved in BMP signal
modulation and may also play a role in the pathway
involving inhibition of hematopoietic progenitor cells
by TGF-beta. SMAD9 mediates the differentiation of
mesenchymal stem cells (MSCs) into tendon-like cells by
inhibiting the osteogenic pathway.
Length = 201
Score = 312 bits (801), Expect = e-108
Identities = 128/148 (86%), Positives = 137/148 (92%)
Query: 131 YQEQPFWASIAYYELNSRVGEVFHCQSHSVIVDGFTNPSNNLNRFCLGQLSNVNRNSTIE 190
YQE +W SIAYYELN+RVGE FH S S+IVDGFT+PSNN +RFCLG LSNVNRNSTIE
Sbjct: 1 YQEPKYWCSIAYYELNNRVGEAFHASSTSIIVDGFTDPSNNSDRFCLGLLSNVNRNSTIE 60
Query: 191 NTRRHIGKGVHLYYVGGEVYAECLSDSAIFVQSRNCNHHHGFHQSTVCKIPAGCSLKIFN 250
NTRRHIGKGVHLYYVGGEVYAECLSDS+IFVQSRNCN+HHGFH +TVCKIP GCSLKIFN
Sbjct: 61 NTRRHIGKGVHLYYVGGEVYAECLSDSSIFVQSRNCNYHHGFHPTTVCKIPPGCSLKIFN 120
Query: 251 NQEFAELLSQSVNHGFEAVYELTKMCTI 278
NQEFA+LLSQSVNHGFEAVYELTKMCTI
Sbjct: 121 NQEFAQLLSQSVNHGFEAVYELTKMCTI 148
>gnl|CDD|199820 cd10495, MH2_R-SMAD, C-terminal Mad Homology 2 (MH2) domain in
receptor regulated SMADs. The MH2 domain is located at
the C-terminus of the SMAD (small mothers against
decapentaplegic) family of proteins, which are signal
transducers and transcriptional modulators that mediate
multiple signaling pathways. The MH2 domain is
responsible for type I receptor interaction,
phosphorylation-triggered homo- and
hetero-oligomerization, and transactivation. It is
negatively regulated by the N-terminal MH1 domain.
Receptor regulated SMADs (R-SMADs) include SMAD1, SMAD2,
SMAD3, SMAD5 and SMAD9. SMAD1 plays an essential role in
bone development and postnatal bone formation through
activation by bone morphogenetic protein (BMP) type 1
receptor kinase. SMAD2 regulates multiple cellular
processes, such as cell proliferation, apoptosis and
differentiation, while SMAD3 modulates signals of
activin and TGF-beta. SMAD5 is involved in BMP signal
modulation, possibly playing a role in the pathway
involving inhibition of hematopoietic progenitor cells
by TGF-beta. SMAD9 (also known as SMAD8) can mediate the
differentiation of mesenchymal stem cells into
tendon-like cells by inhibiting the osteogenic pathway.
Length = 182
Score = 285 bits (732), Expect = 4e-98
Identities = 117/142 (82%), Positives = 127/142 (89%)
Query: 137 WASIAYYELNSRVGEVFHCQSHSVIVDGFTNPSNNLNRFCLGQLSNVNRNSTIENTRRHI 196
W SI+YYELNSRVGE F + S+IVDGFT+PSNN +RFCLG LSNVNRN+TIENTRRHI
Sbjct: 1 WCSISYYELNSRVGEQFKASNPSIIVDGFTDPSNNSDRFCLGLLSNVNRNATIENTRRHI 60
Query: 197 GKGVHLYYVGGEVYAECLSDSAIFVQSRNCNHHHGFHQSTVCKIPAGCSLKIFNNQEFAE 256
G+GVHL+YVGGEVYAECLSDSAIFVQSRNCN HGFH +TVCKIP GCSLKIFNNQ FA+
Sbjct: 61 GRGVHLFYVGGEVYAECLSDSAIFVQSRNCNLRHGFHPATVCKIPPGCSLKIFNNQSFAQ 120
Query: 257 LLSQSVNHGFEAVYELTKMCTI 278
LL QSVN GFEAVYELTKMCTI
Sbjct: 121 LLEQSVNRGFEAVYELTKMCTI 142
>gnl|CDD|199826 cd10985, MH2_SMAD_2_3, C-terminal Mad Homology 2 (MH2) domain in
SMAD2 and SMAD3. The MH2 domain is located at the
C-terminus of the SMAD (small mothers against
decapentaplegic) family of proteins, which are signal
transducers and transcriptional modulators that mediate
multiple signaling pathways. The MH2 domain is
responsible for type I receptor interaction,
phosphorylation-triggered homo- and
hetero-oligomerization, and transactivation. It is
negatively regulated by the N-terminal MH1 domain. SMAD2
and SMAD3 are receptor regulated SMADs (R-SMADs). SMAD2
regulates multiple cellular processes, such as cell
proliferation, apoptosis and differentiation, while
SMAD3 modulates signals of activin and TGF-beta.
Length = 191
Score = 259 bits (662), Expect = 2e-87
Identities = 110/152 (72%), Positives = 126/152 (82%), Gaps = 1/152 (0%)
Query: 129 VPYQEQPFWASIAYYELNSRVGEVFHCQSHSVIVDGFTNPSNNLNRFCLGQLSNVNRNST 188
V Y E FW SI+YYE+N+RVGE FH S+ VDGFT+PSN+ RFCLG LSNVNRN
Sbjct: 1 VTYCEPAFWCSISYYEMNTRVGETFHASQPSLTVDGFTDPSNS-ERFCLGLLSNVNRNPQ 59
Query: 189 IENTRRHIGKGVHLYYVGGEVYAECLSDSAIFVQSRNCNHHHGFHQSTVCKIPAGCSLKI 248
+E TRRHIGKGV LYY+GGEV+AECLSDSAIFVQS NCN +G+H +TVCKIP GC+LKI
Sbjct: 60 VELTRRHIGKGVRLYYIGGEVFAECLSDSAIFVQSPNCNQRYGWHPATVCKIPPGCNLKI 119
Query: 249 FNNQEFAELLSQSVNHGFEAVYELTKMCTISV 280
FNNQEFA LLSQSVN GFEAVY+LT+MCTI +
Sbjct: 120 FNNQEFAALLSQSVNQGFEAVYQLTRMCTIRM 151
>gnl|CDD|199819 cd00050, MH2, C-terminal Mad Homology 2 (MH2) domain. The MH2
domain is found in the SMAD (small mothers against
decapentaplegic) family of proteins and is responsible
for type I receptor interactions,
phosphorylation-triggered homo- and
hetero-oligomerization, and transactivation. It is
negatively regulated by the N-terminal MH1 domain which
prevents it from forming a complex with SMAD4. The MH2
domain is multifunctional and provides SMADs with their
specificity and selectivity, as well as transcriptional
activity. Several transcriptional co-activators and
repressors have also been reported to regulate SMAD
signaling by interacting with the MH2 domain. Mutations
in the MH2 domains of SMAD2 and especially SMAD4 have
been detected in colorectal and other human cancers.
Length = 170
Score = 249 bits (637), Expect = 5e-84
Identities = 112/142 (78%), Positives = 123/142 (86%), Gaps = 1/142 (0%)
Query: 137 WASIAYYELNSRVGEVFHCQSHSVIVDGFTNPSNNLNRFCLGQLSNVNRNSTIENTRRHI 196
W SIAYYELN+RVGE+FH S SV VDGFT+PSN +RFCLGQLSNVNRN TIE TRRHI
Sbjct: 1 WCSIAYYELNTRVGELFHVYSPSVAVDGFTDPSNG-DRFCLGQLSNVNRNETIERTRRHI 59
Query: 197 GKGVHLYYVGGEVYAECLSDSAIFVQSRNCNHHHGFHQSTVCKIPAGCSLKIFNNQEFAE 256
GKGVHLYYVGGEV+AECLSD AIFVQSRN ++ HG H TVCKIP GCS+K+F+NQEFA+
Sbjct: 60 GKGVHLYYVGGEVWAECLSDHAIFVQSRNLDYPHGRHPLTVCKIPPGCSIKVFDNQEFAQ 119
Query: 257 LLSQSVNHGFEAVYELTKMCTI 278
LL QSVN GFE VYELTKMCTI
Sbjct: 120 LLHQSVNTGFEGVYELTKMCTI 141
>gnl|CDD|217398 pfam03166, MH2, MH2 domain. This is the MH2 (MAD homology 2)
domain found at the carboxy terminus of MAD related
proteins such as Smads. This domain is separated from
the MH1 domain by a non-conserved linker region. The MH2
domain mediates interaction with a wide variety of
proteins and provides specificity and selectivity to
Smad function and also is critical for mediating
interactions in Smad oligomers. Unlike MH1, MH2 does not
bind DNA. The well-studied MH2 domain of Smad4 is
composed of five alpha helices and three loops enclosing
a beta sandwich. Smads are involved in the propagation
of TGF-beta signals by direct association with the
TGF-beta receptor kinase which phosphorylates the last
two Ser of a conserved 'SSXS' motif located at the
C-terminus of MH2.
Length = 179
Score = 241 bits (616), Expect = 1e-80
Identities = 92/151 (60%), Positives = 107/151 (70%), Gaps = 2/151 (1%)
Query: 131 YQEQPFWASIAYYELNSRVGEVFHCQSHSVIVDGFTNPSNNLNRFCLGQLSNVNRNSTIE 190
Y E FW SIAYYELN+RVGE F +SV VDGFT+PSN +RFCLGQLSNVNRN IE
Sbjct: 1 YSEPEFWCSIAYYELNTRVGETFKVSGNSVTVDGFTDPSNG-DRFCLGQLSNVNRNEAIE 59
Query: 191 NTRRHIGKGVHLYYVG-GEVYAECLSDSAIFVQSRNCNHHHGFHQSTVCKIPAGCSLKIF 249
TRRHIGKGV L Y GEV+ SDS IFVQS ++ GFH TV KIP G SLK+F
Sbjct: 60 KTRRHIGKGVQLSYKADGEVWVYNRSDSPIFVQSPYLDYPAGFHPLTVHKIPPGASLKVF 119
Query: 250 NNQEFAELLSQSVNHGFEAVYELTKMCTISV 280
+ + F +LL Q+ N GFEAV +L +MCTI +
Sbjct: 120 DFRLFYQLLRQASNSGFEAVDDLRRMCTIRI 150
>gnl|CDD|197770 smart00524, DWB, Domain B in dwarfin family proteins.
Length = 171
Score = 220 bits (562), Expect = 1e-72
Identities = 80/145 (55%), Positives = 100/145 (68%), Gaps = 1/145 (0%)
Query: 136 FWASIAYYELNSRVGEVFHCQSHSVIVDGFTNPSNNLNRFCLGQLSNVNRNSTIENTRRH 195
W IAYYELN+RVGE F S SV VDGFT+PS+ NRFCLGQLSNVNRN E R+H
Sbjct: 1 SWCKIAYYELNTRVGETFKVSSPSVTVDGFTDPSDG-NRFCLGQLSNVNRNEATELIRKH 59
Query: 196 IGKGVHLYYVGGEVYAECLSDSAIFVQSRNCNHHHGFHQSTVCKIPAGCSLKIFNNQEFA 255
IGKGV L Y G+V+ SDS IFVQS + G TV K+P G S+K+F+ ++FA
Sbjct: 60 IGKGVQLSYENGDVWLYNRSDSPIFVQSPYLDEPGGRTLDTVHKLPPGYSIKVFDMEKFA 119
Query: 256 ELLSQSVNHGFEAVYELTKMCTISV 280
+LL++ + GFE VY+L +MCTI +
Sbjct: 120 QLLARELAKGFEGVYDLARMCTIRI 144
>gnl|CDD|199814 cd10490, MH1_SMAD_1_5_9, N-terminal Mad Homology 1 (MH1) domain
in SMAD1, SMAD5 and SMAD9 (also known as SMAD8). The
MH1 is a small DNA-binding domain present in SMAD
(small mothers against decapentaplegic) family of
proteins, which are signal transducers and
transcriptional modulators that mediate multiple
signaling pathways. MH1 binds to the DNA major groove
in an unusual manner via a beta hairpin structure. It
negatively regulates the functions of the MH2 domain,
the C-terminal domain of SMAD. This MH1 domain is found
in SMAD1, SMAD5 and SMAD9, all closely related receptor
regulated SMADs (R-SMADs). SMAD1 plays an essential
role in bone development and postnatal bone formation
through activation by bone morphogenetic protein (BMP)
type 1 receptor kinase. SMAD5 is involved in bone
morphogenetic proteins (BMP) signal modulation and may
also play a role in the pathway involving inhibition of
hematopoietic progenitor cells by TGF-beta. SMAD9
mediates the differentiation of mesenchymal stem cells
(MSCs) into tendon-like cells by inhibiting the
osteogenic pathway.
Length = 124
Score = 146 bits (369), Expect = 4e-44
Identities = 63/68 (92%), Positives = 66/68 (97%)
Query: 23 FTSPAVKKLLGWKQGDEEEKWAEKAVDSLVKKLKKSKGDIEELERALSCPGQPSKCVTIP 82
FTSPAVK+LLGWKQGDEEEKWAEKAVDSLVKKLKK KG +EELE+ALSCPGQPSKCVTIP
Sbjct: 1 FTSPAVKRLLGWKQGDEEEKWAEKAVDSLVKKLKKKKGALEELEKALSCPGQPSKCVTIP 60
Query: 83 RSLDGRLQ 90
RSLDGRLQ
Sbjct: 61 RSLDGRLQ 68
>gnl|CDD|199823 cd10498, MH2_SMAD_4, C-terminal Mad Homology 2 (MH2) domain in
SMAD4. The MH2 domain is located at the C-terminus of
the SMAD (small mothers against decapentaplegic) family
of proteins, which are signal transducers and
transcriptional modulators that mediate multiple
signaling pathways. The MH2 domain is responsible for
type I receptor interaction, phosphorylation-triggered
homo- and hetero-oligomerization, and transactivation.
It is negatively regulated by the N-terminal MH1 domain.
SMAD4, which belongs to the Dwarfin family of proteins,
is involved in many cell functions such as
differentiation, apoptosis, gastrulation, embryonic
development and the cell cycle. SMAD4 binds receptor
regulated SMADs (R-SMADs) such as SMAD1 or SMAD2, and
forms an oligomeric complex that binds to DNA and serves
as a transcription factor. SMAD4 is often mutated in
several cancers, such as multiploid colorectal cancer,
cervical cancer and pancreatic carcinoma, as well as in
juvenile polyposis syndrome.
Length = 222
Score = 124 bits (314), Expect = 1e-34
Identities = 59/139 (42%), Positives = 79/139 (56%), Gaps = 6/139 (4%)
Query: 136 FWASIAYYELNSRVGEVFHCQS--HSVIVDGFTNPSNNLNRFCLGQLSNVNRNSTIENTR 193
+W SIAY+EL+++VGE F S +V VDG+ +PS NRFCLGQLSNV+R E R
Sbjct: 3 YWCSIAYFELDTQVGETFKVPSSCPTVTVDGYVDPSG-GNRFCLGQLSNVHRTEASERAR 61
Query: 194 RHIGKGVHLYYVG-GEVYAECLSDSAIFVQSRNCNHHHGFHQ-STVCKIPAGCSLKIFN- 250
HIGKGV L G G+V+ CLSD ++FVQS + G V KI +K+F+
Sbjct: 62 LHIGKGVQLDCKGEGDVWLRCLSDHSVFVQSYYLDREAGRAPGDAVHKIYPSAYIKVFDL 121
Query: 251 NQEFAELLSQSVNHGFEAV 269
Q ++ Q+ A
Sbjct: 122 RQCHRQMQQQAATAQAAAA 140
>gnl|CDD|199812 cd10488, MH1_R-SMAD, N-terminal Mad Homology 1 (MH1) domain of
receptor regulated SMADs. The MH1 is a small
DNA-binding domain present in SMAD (small mothers
against decapentaplegic) family of proteins, which are
signal transducers and transcriptional modulators that
mediate multiple signaling pathways. It binds to the
major groove in an unusual manner via a beta hairpin
structure. It negatively regulates the functions of
the MH2 domain, the C-terminal domain of SMAD. This MH1
domain is found in all receptor regulated SMADs
(R-SMADs) including SMAD1, SMAD2, SMAD3, SMAD5 and
SMAD9. SMAD1 plays an essential role in bone
development and postnatal bone formation through
activation by bone morphogenetic protein (BMP) type 1
receptor kinase. SMAD2 regulates multiple cellular
processes, such as cell proliferation, apoptosis and
differentiation, while SMAD3 modulates signals of
activin and TGF-beta. SMAD4, a common mediator SMAD
(co-SMAD) binds R-SMADs, forming an oligomeric complex
that binds to DNA and serves as a transcription factor.
SMAD5 is involved in bone morphogenetic proteins (BMP)
signal modulation, possibly playing a role in the
pathway involving inhibition of hematopoietic
progenitor cells by TGF-beta. SMAD9 (also known as
SMAD8) can mediate the differentiation of mesenchymal
stem cells (MSCs) into tendon-like cells by inhibiting
the osteogenic pathway.
Length = 123
Score = 108 bits (271), Expect = 1e-29
Identities = 48/68 (70%), Positives = 55/68 (80%), Gaps = 4/68 (5%)
Query: 26 PAVKKLLGWKQG---DEEEKWAEKAVDSLVKKLKKSKGDIEELERALSCPGQPSKCVTIP 82
P VK+LLGWK+G EEEKWAEKAV SLVKKLKK KG +EELE+A+S ++CVTIP
Sbjct: 1 PIVKRLLGWKKGEQNGEEEKWAEKAVKSLVKKLKK-KGQLEELEKAISTQNVNTRCVTIP 59
Query: 83 RSLDGRLQ 90
RSLDGRLQ
Sbjct: 60 RSLDGRLQ 67
>gnl|CDD|199815 cd10491, MH1_SMAD_2_3, N-terminal Mad Homology 1 (MH1) domain in
SMAD2 and SMAD3. The MH1 is a small DNA-binding domain
present in SMAD (small mothers against decapentaplegic)
family of proteins, which are signal transducers and
transcriptional modulators that mediate multiple
signaling pathways. MH1 binds to the DNA major groove
in an unusual manner via a beta hairpin structure. It
negatively regulates the functions of the MH2 domain,
the C-terminal domain of SMAD. This MH1 is found in
SMAD2 as well as SMAD3. SMAD2 mediates the signal of
the transforming growth factor (TGF)-beta, and thereby
regulates multiple cellular processes, such as cell
proliferation, apoptosis, and differentiation. It plays
a role in the transmission of extracellular signals
from ligands of the TGF-beta superfamily growth factors
into the cell nucleus. SMAD3 modulates signals of
activin and TGF-beta. It binds SMAD4, enabling its
transmigration into the nucleus where it forms
complexes with other proteins and acts as a
transcription factor. Increased SMAD3 activity has been
implicated in the pathogenesis of scleroderma.
Length = 124
Score = 104 bits (262), Expect = 3e-28
Identities = 44/69 (63%), Positives = 56/69 (81%), Gaps = 3/69 (4%)
Query: 24 TSPAVKKLLGWKQG--DEEEKWAEKAVDSLVKKLKKSKGDIEELERALSCPGQPSKCVTI 81
T P VK+LLGWK+G +EEKW+EKAV SLVKKLKK+ G ++ELE+A++ +KC+TI
Sbjct: 1 TPPVVKRLLGWKKGENGQEEKWSEKAVKSLVKKLKKT-GGLDELEKAITTQNSNTKCITI 59
Query: 82 PRSLDGRLQ 90
PRSLDGRLQ
Sbjct: 60 PRSLDGRLQ 68
>gnl|CDD|199811 cd00049, MH1, N-terminal Mad Homology 1 (MH1) domain. The MH1 is
a small DNA-binding domain present in SMAD (small
mothers against decapentaplegic) family of proteins,
which are signal transducers and transcriptional
modulators that mediate multiple signaling pathways.
MH1 binds to the DNA major groove in an unusual manner
via a beta hairpin structure. It negatively regulates
the functions of the MH2 domain, the C-terminal domain
of SMAD. Receptor-regulated SMAD proteins (R-SMADs,
including SMAD1, SMAD2, SMAD3, SMAD5, and SMAD9) are
activated by phosphorylation by transforming growth
factor (TGF)-beta type I receptors. The active R-SMAD
associates with a common mediator SMAD (Co-SMAD or
SMAD4) and other cofactors, which together translocate
to the nucleus to regulate gene expression. The
inhibitory or antagonistic SMADs (I-SMADs, including
SMAD6 and SMAD7) negatively regulate TGF-beta signaling
by competing with R-SMADs for type I receptor or
Co-SMADs. MH1 domains of R-SMAD and SMAD4 contain a
nuclear localization signal as well as DNA-binding
activity. The activated R-SMAD/SMAD4 complex then binds
with very low affinity to a DNA sequence CAGAC called
SMAD-binding element (SBE) via the MH1 domain.
Length = 121
Score = 102 bits (256), Expect = 2e-27
Identities = 47/73 (64%), Positives = 55/73 (75%), Gaps = 2/73 (2%)
Query: 26 PAVKKLLGWKQGDEEEKWAEKAVDSLVKKLKKSKGDIEELERALSCPG-QPSKCVTIPRS 84
P VK+LLGWKQG EEEKWA+KAV SLVKKLK+ K ++ LE+A++ G PSKCVTIPRS
Sbjct: 1 PIVKRLLGWKQGGEEEKWAKKAVKSLVKKLKE-KKQLDSLEKAITTQGGVPSKCVTIPRS 59
Query: 85 LDGRLQQIETPPP 97
LDGRLQ
Sbjct: 60 LDGRLQVAHRKGL 72
>gnl|CDD|199821 cd10496, MH2_I-SMAD, C-terminal Mad Homology 2 (MH2) domain in
Inhibitory SMADs. The MH2 domain is located at the
C-terminus of the SMAD (small mothers against
decapentaplegic) family of proteins, which are signal
transducers and transcriptional modulators that mediate
multiple signaling pathways. The MH2 domain is
responsible for type I receptor interaction,
phosphorylation-triggered homo- and
hetero-oligomerization, and transactivation. It is
negatively regulated by the N-terminal MH1 domain, which
prevents it from forming a complex with SMAD4. SMAD6 and
SMAD7 are inhibitory SMADs (I-SMADs) that function as
negative regulators of signaling mediated by the
TGF-beta superfamily. SMAD6 specifically inhibits bone
morphogenetic protein (BMP) type I receptor mediated
signaling, while SMAD7 enhances muscle differentiation
and is often associated with cancer, tissue fibrosis and
inflammatory diseases.
Length = 165
Score = 78.2 bits (193), Expect = 1e-17
Identities = 39/122 (31%), Positives = 58/122 (47%), Gaps = 5/122 (4%)
Query: 137 WASIAYYELNSRVGEVFHCQSHSVIVDGFTNPSNNLNRFCLGQL-SNVNRNSTIENTRRH 195
W +IAY+EL RVG ++ + +V + F + + FCLG L N + + R
Sbjct: 1 WCTIAYWELRERVGRLYPVKQPAVNI--FDDLPKG-DGFCLGALNRQGNASEAVARVRSK 57
Query: 196 IGKGVHLYYVGGEVYAECLSDSAIFVQSRNCNHHHGFHQSTVCKIPAGCSLKIFNNQEFA 255
IG GV L V+ S+ IFV S + + V K+P G SLK+F+ + A
Sbjct: 58 IGLGVTLSREPDGVWIYNRSEYPIFVNSPTLDSPPSRNL-LVTKVPPGYSLKVFDYERAA 116
Query: 256 EL 257
L
Sbjct: 117 LL 118
>gnl|CDD|214708 smart00523, DWA, Domain A in dwarfin family proteins.
Length = 109
Score = 74.7 bits (184), Expect = 6e-17
Identities = 32/53 (60%), Positives = 41/53 (77%), Gaps = 3/53 (5%)
Query: 39 EEEKWAEKAVDSLVKKLKKSKGDIEELERALSCPG-QPSKCVTIPRSLDGRLQ 90
EEKWA+KA +SL+KKLKK + +EEL +A+ G P++CV IPRSLDGRLQ
Sbjct: 1 VEEKWAKKATESLLKKLKKKQ--LEELLQAVESKGGPPTRCVLIPRSLDGRLQ 51
>gnl|CDD|199816 cd10492, MH1_SMAD_4, N-terminal Mad Homology 1 (MH1) domain in
SMAD4. The MH1 is a small DNA-binding domain present
in SMAD (small mothers against decapentaplegic) family
of proteins, which are signal transducers and
transcriptional modulators that mediate multiple
signaling pathways. MH1 binds to the DNA major groove
in an unusual manner via a beta hairpin structure. It
negatively regulates the functions of the MH2 domain,
the C-terminal domain of SMAD. This MH1 belongs to
SMAD4, a common mediator SMAD (co-SMAD), which belongs
to the Dwarfin family of proteins and is involved in
many cell functions such as differentiation, apoptosis,
gastrulation, embryonic development and cell cycle.
SMAD4 binds receptor regulated SMADs (R-SMADs) such as
SMAD1 or SMAD2, and forms an oligomeric complex that
binds to DNA and serves as a transcription factor.
SMAD4 is often mutated in several cancers, such as
multiploid colorectal cancer and pancreatic carcinoma,
as well as in juvenile polyposis syndrome (JPS).
Length = 125
Score = 72.9 bits (179), Expect = 4e-16
Identities = 32/64 (50%), Positives = 46/64 (71%), Gaps = 1/64 (1%)
Query: 28 VKKLLGWKQGDEEEKWAEKAVDSLVKKLKKSKGDIEELERALSCPG-QPSKCVTIPRSLD 86
V L+ +QG E E +A++A++SLVKKLK + +++ L A++ G PSKCVTI R+LD
Sbjct: 7 VHSLMCHRQGGESESFAKRAIESLVKKLKDKRDELDSLITAITSNGAHPSKCVTIQRTLD 66
Query: 87 GRLQ 90
GRLQ
Sbjct: 67 GRLQ 70
>gnl|CDD|217397 pfam03165, MH1, MH1 domain. The MH1 (MAD homology 1) domain is
found at the amino terminus of MAD related proteins
such as Smads. This domain is separated from the MH2
domain by a non-conserved linker region. The crystal
structure of the MH1 domain shows that a highly
conserved 11 residue beta hairpin is used to bind the
DNA consensus sequence GNCN in the major groove, shown
to be vital for the transcriptional activation of
target genes. Not all examples of MH1 can bind to DNA
however. Smad2 cannot bind DNA and has a large
insertion within the hairpin that presumably abolishes
DNA binding. A basic helix (H2) in MH1 with the nuclear
localisation signal KKLKK has been shown to be
essential for Smad3 nuclear import. Smads also use the
MH1 domain to interact with transcription factors such
as Jun, TFE3, Sp1, and Runx.
Length = 103
Score = 70.1 bits (172), Expect = 2e-15
Identities = 33/48 (68%), Positives = 39/48 (81%), Gaps = 1/48 (2%)
Query: 44 AEKAVDSLVKKLKKSKGDIEELERALSCPG-QPSKCVTIPRSLDGRLQ 90
A+KAV+SL+KKLKK K +EELE A+ G P+KCVTIPRSLDGRLQ
Sbjct: 1 AKKAVESLLKKLKKKKQQLEELELAVESRGGPPTKCVTIPRSLDGRLQ 48
>gnl|CDD|199824 cd10499, MH2_SMAD_6, C-terminal Mad Homology 2 (MH2) domain in
SMAD6. The MH2 domain is located at the C-terminus of
the SMAD (small mothers against decapentaplegic) family
of proteins, which are signal transducers and
transcriptional modulators that mediate multiple
signaling pathways. The MH2 domain is responsible for
type I receptor interaction, phosphorylation-triggered
homo- and hetero-oligomerization, and transactivation.
It is negatively regulated by the N-terminal MH1 domain,
which prevents it from forming a complex with SMAD4.
SMAD6, an inhibitory or antagonistic SMAD (I-SMAD), acts
as a negative regulator of signaling mediated by the
TGF-beta superfamily of ligands, by competing with SMAD4
and preventing the transcription of SMAD4's gene
products. SMAD6 specifically inhibits bone morphogenetic
protein (BMP) type I receptor mediated signaling. SMAD6
and SMAD7 act as critical mediators for effective
TGF-beta I-mediated suppression of
Interleukin-1/Toll-like receptor (IL-1R/TLR) signaling
through simultaneous binding to Pellino-1, an adaptor
protein of interleukin-1 receptor associated kinase 1
(IRAK1), via their MH2 domains.
Length = 174
Score = 61.4 bits (149), Expect = 2e-11
Identities = 38/114 (33%), Positives = 58/114 (50%), Gaps = 4/114 (3%)
Query: 137 WASIAYYELNSRVGEVFHCQSHSVIVDGFTNPSNNLNRFCLGQLSNVNRNSTIENTRRHI 196
W S+AY+E +RVG ++ SV + F + + FCLGQL+ R+ ++ TR I
Sbjct: 10 WCSVAYWEHRTRVGRLYAVYDQSVSI--FYDLPQG-SGFCLGQLNLEQRSESVRRTRSKI 66
Query: 197 GKGVHLYYVGGEVYAECLSDSAIFVQSRNCNHHHGFHQSTVCKIPAGCSLKIFN 250
G G+ L V+A S+ IFV S + V K+P G S+K+F+
Sbjct: 67 GYGILLSKEPDGVWAYNRSEHPIFVNSPTLDIPGS-RTLVVRKVPPGYSIKVFD 119
>gnl|CDD|199825 cd10500, MH2_SMAD_7, C-terminal Mad Homology 2 (MH2) domain in
SMAD7. The MH2 domain is located at the C-terminus of
the SMAD (small mothers against decapentaplegic) family
of proteins, which are signal transducers and
transcriptional modulators that mediate multiple
signaling pathways. The MH2 domain is responsible for
type I receptor interaction, phosphorylation-triggered
homo- and hetero-oligomerization, and transactivation.
It is negatively regulated by the N-terminal MH1 domain,
which prevents it from forming a complex with SMAD4.
SMAD7, an inhibitory or antagonistic SMAD (I-SMAD), acts
as a negative regulator of signaling mediated by the
TGF-beta superfamily of ligands, by blocking TGF-beta
type 1 and activin association with the receptor as well
as access to SMAD2. SMAD7 enhances muscle
differentiation, playing pivotal roles in embryonic
development and adult homoeostasis. SMAD7 and SMAD6 act
as critical mediators for effective TGF-beta I-mediated
suppression of Interleukin-1/Toll-like receptor
(IL-1R/TLR) signaling through simultaneous binding to
Pellino-1, an adaptor protein of interleukin-1 receptor
associated kinase 1(IRAK1), via their MH2 domains.
Altered expression of SMAD7 is often associated with
cancer, tissue fibrosis and inflammatory diseases.
Length = 171
Score = 53.1 bits (127), Expect = 1e-08
Identities = 40/134 (29%), Positives = 67/134 (50%), Gaps = 5/134 (3%)
Query: 133 EQPFWASIAYYELNSRVGEVFHCQSHSVIVDGFTNPSNNLNRFCLGQLSNVNRNSTIENT 192
+Q W +AY+E +RVG ++ Q S+ D F + N FCLGQL++ N++ ++
Sbjct: 4 DQSHWCVVAYWEEKTRVGRLYSVQEPSL--DIFYDLPQG-NGFCLGQLNSDNKSQLVQKV 60
Query: 193 RRHIGKGVHLYYVGGEVYAECLSDSAIFVQSRNCNHHHGFHQSTVCKIPAGCSLKIFNNQ 252
R IG G+ L V+ S IF++S ++ V K+ G S+K F+ +
Sbjct: 61 RSKIGYGIQLTREVDGVWVYNRSSYPIFIKSATLDNPDS-RTLLVHKVFPGFSIKAFDYE 119
Query: 253 EFAELLSQSVNHGF 266
+ A L + +H F
Sbjct: 120 K-AYSLQRPNDHEF 132
>gnl|CDD|220732 pfam10401, IRF-3, Interferon-regulatory factor 3. This is the
interferon-regulatory factor 3 chain of the
hetero-dimeric structure which also contains the shorter
chain CREB-binding protein. These two subunits make up
the DRAF1 (double-stranded RNA-activated factor 1).
Viral dsRNA produced during viral transcription or
replication leads to the activation of DRAF1. The
DNA-binding specificity of DRAF1 correlates with
transcriptional induction of ISG
(interferon-alpha,beta-stimulated gene). IRF-3 preexists
in the cytoplasm of uninfected cells and translocates to
the nucleus following viral infection. Translocation of
IRF-3 is accompanied by an increase in serine and
threonine phosphorylation, and association with the CREB
coactivator occurs only after infection.
Length = 180
Score = 33.0 bits (76), Expect = 0.081
Identities = 18/80 (22%), Positives = 31/80 (38%), Gaps = 8/80 (10%)
Query: 189 IENTRR---HIGKGVHLYYVGGEVYAECLSDSAIFVQSRNCNHHHGFHQSTVCKIPAGCS 245
E TRR H+ +G+ L G +YA+ L +F K+
Sbjct: 62 REYTRRLLKHLERGLLLEVNGQGIYAKRLCQCRVFWSGPEAPGSD-----RPNKLERNVP 116
Query: 246 LKIFNNQEFAELLSQSVNHG 265
+K+F+ Q+F L++
Sbjct: 117 VKLFDLQQFLRELARFPEGR 136
>gnl|CDD|177547 PHA03164, PHA03164, hypothetical protein; Provisional.
Length = 88
Score = 31.1 bits (70), Expect = 0.16
Identities = 18/50 (36%), Positives = 21/50 (42%), Gaps = 5/50 (10%)
Query: 93 ETPPPAYSPP--QDEKHGSQSPHSENAMDTGISSDVTPVPYQEQPFWASI 140
TPPP+YS D G SPH EN DT + P P + W
Sbjct: 5 RTPPPSYSEVLMMDVMDGQVSPHQEN--DTSFVECLPP-PQISRTAWNLW 51
>gnl|CDD|235723 PRK06170, PRK06170, amidase; Provisional.
Length = 490
Score = 30.0 bits (68), Expect = 1.6
Identities = 15/48 (31%), Positives = 22/48 (45%), Gaps = 10/48 (20%)
Query: 94 TPPPAYSPPQDEKHGSQSPHSENAMDTGISSDVTPVPYQEQPFWASIA 141
TP PA+ P D H+ + ++ I D PY +Q WA +A
Sbjct: 399 TPTPAF--PHD--------HAPDPLERRIDIDGVSYPYWDQLVWAGLA 436
>gnl|CDD|151031 pfam10458, Val_tRNA-synt_C, Valyl tRNA synthetase tRNA binding
arm. This domain is found at the C-terminus of Valyl
tRNA synthetases.
Length = 66
Score = 27.2 bits (61), Expect = 2.4
Identities = 13/29 (44%), Positives = 18/29 (62%)
Query: 45 EKAVDSLVKKLKKSKGDIEELERALSCPG 73
EK L K+L K + +IE L++ LS PG
Sbjct: 3 EKERARLEKELAKLQKEIERLQKKLSNPG 31
>gnl|CDD|234938 PRK01297, PRK01297, ATP-dependent RNA helicase RhlB; Provisional.
Length = 475
Score = 29.1 bits (65), Expect = 3.0
Identities = 17/65 (26%), Positives = 25/65 (38%), Gaps = 1/65 (1%)
Query: 51 LVKKLKKSKGDIEELERALSCPGQPSKCVTIPRSLDGRLQQIETPPPAYSPPQDEKHGSQ 110
++K LKK G E + A + P P+ P + PA + P+ EK
Sbjct: 1 MLKALKKIFGKGEAEQPAPA-PPSPAAAPAPPPPAKTAAPATKAAAPAAAAPRAEKPKKD 59
Query: 111 SPHSE 115
P E
Sbjct: 60 KPRRE 64
>gnl|CDD|199818 cd10494, MH1_SMAD_7, N-terminal Mad Homology 1 (MH1) domain in
SMAD7. The MH1 is a small DNA-binding domain present
in SMAD (small mothers against decapentaplegic) family
of proteins. It binds to the major groove in an unusual
manner via a beta hairpin structure. It negatively
regulates the functions of the MH2 domain, the
C-terminal domain of SMAD. This MH1 belongs to SMAD7,
an inhibitory SMAD (I-SMAD) or antagonistic SMAD, which
acts as a negative regulator of signaling mediated by
TGF-beta superfamily ligands, by blocking TGF-beta type
1 and activin association with the receptor as well as
access to SMAD2. SMAD7 enhances muscle differentiation,
playing pivotal roles in embryonic development and
adult homoeostasis. Altered expression of SMAD7 is
often associated with cancer, tissue fibrosis and
inflammatory diseases.
Length = 123
Score = 27.9 bits (62), Expect = 3.1
Identities = 17/50 (34%), Positives = 27/50 (54%), Gaps = 3/50 (6%)
Query: 50 SLVKKLKKSKGDIEELERALSCPGQP-SKCVTIPRSLDGRLQQIETPPPA 98
S++KKLK+ + +E L +A+ G + C+ +P LD RL Q P
Sbjct: 26 SVLKKLKERQ--LEGLLQAVESRGGARTPCLLLPARLDARLGQQSYSLPL 73
>gnl|CDD|224984 COG2073, CbiG, Cobalamin biosynthesis protein CbiG [Coenzyme
metabolism].
Length = 298
Score = 28.9 bits (65), Expect = 3.2
Identities = 9/34 (26%), Positives = 13/34 (38%)
Query: 40 EEKWAEKAVDSLVKKLKKSKGDIEELERALSCPG 73
K E + L KKL E + + + PG
Sbjct: 236 ALKADEPGLIQLAKKLGVPFITFEFVLKEVGVPG 269
>gnl|CDD|189762 pfam00901, Orbi_VP5, Orbivirus outer capsid protein VP5.
cryoelectron microscopy indicates that VP5 is a trimer
implying that there are 360 copies of VP5 per virion.
Length = 507
Score = 28.9 bits (65), Expect = 3.4
Identities = 16/47 (34%), Positives = 25/47 (53%), Gaps = 5/47 (10%)
Query: 28 VKKLLGW--KQGDEEEK---WAEKAVDSLVKKLKKSKGDIEELERAL 69
V K + K +EEEK EKA+ S +K +K+ ++ L +AL
Sbjct: 124 VYKFMKGEAKVEEEEEKQMEILEKALKSYLKIVKEENKSLQRLAKAL 170
>gnl|CDD|217942 pfam04179, Init_tRNA_PT, Initiator tRNA phosphoribosyl transferase.
This enzyme (EC:2.4.2.-) modifies exclusively the
initiator tRNA in position 64 using
5'-phosphoribosyl-1'-pyrophosphate as the modification
donor. As the initiator tRNA participates both in the
initiation and elongation of translation, the
2'-O-ribosyl phosphate modification discriminates the
initiator tRNAs from the elongator tRNAs.
Length = 441
Score = 28.5 bits (64), Expect = 4.0
Identities = 16/39 (41%), Positives = 20/39 (51%)
Query: 37 GDEEEKWAEKAVDSLVKKLKKSKGDIEELERALSCPGQP 75
D E EK +D VK L K DIE+L + L P +P
Sbjct: 140 SDSEHSQIEKRIDGFVKSLLKLGLDIEKLRQQLGKPLRP 178
>gnl|CDD|203622 pfam07355, GRDB, Glycine/sarcosine/betaine reductase selenoprotein
B (GRDB). This family represents a conserved region
approximately 350 residues long within the selenoprotein
B component of the bacterial glycine, sarcosine and
betaine reductase complexes.
Length = 349
Score = 28.5 bits (64), Expect = 4.7
Identities = 12/18 (66%), Positives = 15/18 (83%)
Query: 39 EEEKWAEKAVDSLVKKLK 56
EE+ A++AVD LVKKLK
Sbjct: 183 HEERGAKRAVDMLVKKLK 200
>gnl|CDD|148523 pfam06952, PsiA, PsiA protein. This family consists of several
Enterobacterial PsiA proteins. The function of PsiA is
unknown although it is thought that it may affect the
generation of an SOS signal in Escherichia coli.
Length = 238
Score = 28.2 bits (63), Expect = 4.8
Identities = 16/57 (28%), Positives = 25/57 (43%), Gaps = 14/57 (24%)
Query: 83 RSLDGR-------LQQIETPPPAYSPPQDEKHGSQSPHSENAMDTGISS--DVTPVP 130
R L+G ++I P Y+ P++ GS E A+D I S + P+P
Sbjct: 46 RVLNGSGRINATDARRI---PGLYTDPEN--RGSSLKQVEEALDVLIESGGEYCPLP 97
>gnl|CDD|184088 PRK13495, PRK13495, chemoreceptor glutamine deamidase CheD;
Provisional.
Length = 159
Score = 27.5 bits (61), Expect = 5.1
Identities = 14/34 (41%), Positives = 23/34 (67%)
Query: 33 GWKQGDEEEKWAEKAVDSLVKKLKKSKGDIEELE 66
G K+ D+ K+A+ A+ +LV++LKK +E LE
Sbjct: 52 GGKETDKPGKYADTAIKTLVEELKKMGAKVERLE 85
>gnl|CDD|221533 pfam12329, TMF_DNA_bd, TATA element modulatory factor 1 DNA
binding. This is the middle region of a family of TATA
element modulatory factor 1 proteins conserved in
eukaryotes that contains at its N-terminal section a
number of leucine zippers that could potentially form
coiled coil structures. The whole proteins bind to the
TATA element of some RNA polymerase II promoters and
repress their activity. by competing with the binding
of TATA binding protein. TMFs are evolutionarily
conserved golgins that bind Rab6, a ubiquitous ras-like
GTP-binding Golgi protein, and contribute to Golgi
organisation in animal and plant cells.
Length = 74
Score = 26.5 bits (59), Expect = 5.1
Identities = 15/43 (34%), Positives = 22/43 (51%), Gaps = 6/43 (13%)
Query: 28 VKKLLGWKQGDEEEKWAEKAVDSLVKKLKKSKGDIEELERALS 70
+KKL + K EK + L KKL+K + ++E LE L
Sbjct: 35 IKKL------RAKNKELEKEIAELKKKLEKLEKELENLEERLK 71
>gnl|CDD|218440 pfam05110, AF-4, AF-4 proto-oncoprotein. This family consists of
AF4 (Proto-oncogene AF4) and FMR2 (Fragile X E mental
retardation syndrome) nuclear proteins. These proteins
have been linked to human diseases such as acute
lymphoblastic leukaemia and mental retardation. The
family also contains a Drosophila AF4 protein homologue
Lilliputian which contains an AT-hook domain.
Lilliputian represents a novel pair-rule gene that acts
in cytoskeleton regulation, segmentation and
morphogenesis in Drosophila.
Length = 1154
Score = 28.3 bits (63), Expect = 5.5
Identities = 24/93 (25%), Positives = 39/93 (41%), Gaps = 8/93 (8%)
Query: 82 PRSLDGRLQQIETPPPAYSPPQDEKHGSQS-----PHSENAMDTGISSDVTPVPYQEQPF 136
PR L+ +Q E PP + +H Q+ +AM ++ V P+ Q+Q
Sbjct: 176 PRDLEVNVQSPERPPDSLVLLPSSQHSVQNFPPSLMSKSSAMQQKPTAYVRPMDGQDQAP 235
Query: 137 WASIAYYELNSRVGEVFHCQSHSVIVDGFTNPS 169
S EL S + E + QS +D +P+
Sbjct: 236 DESP---ELKSSIEESYGQQSFGKTMDELKSPA 265
>gnl|CDD|233720 TIGR02091, glgC, glucose-1-phosphate adenylyltransferase. This
enzyme, glucose-1-phosphate adenylyltransferase, is also
called ADP-glucose pyrophosphorylase. The plant form is
an alpha2,beta2 heterodimer, allosterically regulated in
plants. Both subunits are homologous and included in
this model. In bacteria, both homomeric forms of GlgC
and more active heterodimers of GlgC and GlgD have been
described. This model describes the GlgC subunit only.
This enzyme appears in variants of glycogen synthesis
pathways that use ADP-glucose, rather than UDP-glucose
as in animals [Energy metabolism, Biosynthesis and
degradation of polysaccharides].
Length = 361
Score = 28.0 bits (63), Expect = 6.9
Identities = 10/49 (20%), Positives = 21/49 (42%), Gaps = 4/49 (8%)
Query: 159 SVIVDGFTNPSNNLNRFCLGQLSNVNRNSTIENT----RRHIGKGVHLY 203
S++ +G ++ LG + ST+E++ IG+G +
Sbjct: 295 SLVSEGCIISGATVSHSVLGIRVRIGSGSTVEDSVIMGDVGIGRGAVIR 343
>gnl|CDD|183780 PRK12831, PRK12831, putative oxidoreductase; Provisional.
Length = 464
Score = 27.7 bits (62), Expect = 7.8
Identities = 13/25 (52%), Positives = 15/25 (60%)
Query: 144 ELNSRVGEVFHCQSHSVIVDGFTNP 168
EL +RV EV H + VI D TNP
Sbjct: 317 ELPARVEEVHHAKEEGVIFDLLTNP 341
>gnl|CDD|153029 pfam12595, Rhomboid_SP, Rhomboid serine protease. This domain
family is found in eukaryotes, and is approximately 210
amino acids in length. The family is found in
association with pfam01694. Rhomboid is a
seven-transmembrane spanning protein that resides in the
Golgi and acts as a serine protease to cleave Spitz.
Length = 204
Score = 27.2 bits (60), Expect = 8.6
Identities = 14/67 (20%), Positives = 27/67 (40%), Gaps = 13/67 (19%)
Query: 35 KQGDEEEKWAEKAVDSLVKKLKKSKGDIEELERALSCPGQPSKCVTIPRSLDGRLQQIET 94
+ D ++W +++ ++ + K +++ R L P Q + L ET
Sbjct: 3 EDSDSTQRWQRRSLRHCSQRYGRLK---DQVHRELELPSQDNV----------SLASTET 49
Query: 95 PPPAYSP 101
P P Y P
Sbjct: 50 PAPLYVP 56
>gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC,
primarily archaeal type. SMC (structural maintenance of
chromosomes) proteins bind DNA and act in organizing and
segregating chromosomes for partition. SMC proteins are
found in bacteria, archaea, and eukaryotes. It is found
in a single copy and is homodimeric in prokaryotes, but
six paralogs (excluded from this family) are found in
eukarotes, where SMC proteins are heterodimeric. This
family represents the SMC protein of archaea and a few
bacteria (Aquifex, Synechocystis, etc); the SMC of other
bacteria is described by TIGR02168. The N- and
C-terminal domains of this protein are well conserved,
but the central hinge region is skewed in composition
and highly divergent [Cellular processes, Cell division,
DNA metabolism, Chromosome-associated proteins].
Length = 1164
Score = 27.7 bits (62), Expect = 8.8
Identities = 11/33 (33%), Positives = 17/33 (51%)
Query: 38 DEEEKWAEKAVDSLVKKLKKSKGDIEELERALS 70
+EE + E A+ L +L K + +ELE L
Sbjct: 867 EEELEELEAALRDLESRLGDLKKERDELEAQLR 899
>gnl|CDD|234621 PRK00082, hrcA, heat-inducible transcription repressor;
Provisional.
Length = 339
Score = 27.4 bits (62), Expect = 9.7
Identities = 21/73 (28%), Positives = 32/73 (43%), Gaps = 16/73 (21%)
Query: 28 VKKLLGWKQGDEEEKWAEKAVDSLVKKLKKSKGDIEE-LERA------LSCPGQPSKCVT 80
V LL K EEE+ ++ K L + +E+ L+ A L+ G + V
Sbjct: 77 VDHLLEVKPLSEEER------RAIEKFLDERGVSLEDVLQEAAQLLSELT--GYTA-VVL 127
Query: 81 IPRSLDGRLQQIE 93
P+ D RL+ IE
Sbjct: 128 TPKLSDSRLKHIE 140
Database: CDD.v3.10
Posted date: Mar 20, 2013 7:55 AM
Number of letters in database: 10,937,602
Number of sequences in database: 44,354
Lambda K H
0.315 0.131 0.393
Gapped
Lambda K H
0.267 0.0730 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 14,334,122
Number of extensions: 1299262
Number of successful extensions: 1488
Number of sequences better than 10.0: 1
Number of HSP's gapped: 1463
Number of HSP's successfully gapped: 43
Length of query: 291
Length of database: 10,937,602
Length adjustment: 96
Effective length of query: 195
Effective length of database: 6,679,618
Effective search space: 1302525510
Effective search space used: 1302525510
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.6 bits)
S2: 59 (26.5 bits)